Baillie Gifford & CO Sage Therapeutics, Inc. Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$10.58 - $17.9 $184,970 - $312,945	-17,483 Reduced 21.63%	63,333 $687,000
Q1 2024 May 01, 2024	SELL	$18.62 - $26.95 $73,530 - $106,425	-3,949 Reduced 4.66%	80,816 $1.51 Million
Q4 2023 Jan 26, 2024	SELL	$17.1 - $22.26 $63,988 - $83,296	-3,742 Reduced 4.23%	84,765 $1.84 Million
Q3 2023 Nov 13, 2023	SELL	$16.75 - $48.98 $87,301 - $255,283	-5,212 Reduced 5.56%	88,507 $1.82 Million
Q2 2023 Jul 28, 2023	SELL	$40.65 - $59.54 $53,901 - $78,950	-1,326 Reduced 1.4%	93,719 $4.41 Million
Q1 2023 May 03, 2023	BUY	$37.27 - $46.57 $5,963 - $7,451	160 Added 0.17%	95,045 $3.99 Million
Q4 2022 Jan 24, 2023	BUY	$32.2 - $43.61 $112,378 - $152,198	3,490 Added 3.82%	94,885 $3.62 Million
Q3 2022 Oct 27, 2022	BUY	$32.28 - $43.27 $95,193 - $127,603	2,949 Added 3.33%	91,395 $3.58 Million
Q2 2022 Aug 08, 2022	SELL	$27.52 - $37.99 $284,006 - $392,056	-10,320 Reduced 10.45%	88,446 $2.86 Million
Q1 2022 May 05, 2022	BUY	$30.71 - $45.71 $257,779 - $383,689	8,394 Added 9.29%	98,766 $3.27 Million
Q4 2021 Jan 20, 2022	BUY	$37.06 - $47.11 $150,982 - $191,926	4,074 Added 4.72%	90,372 $3.85 Million
Q3 2021 Oct 19, 2021	BUY	$40.26 - $57.37 $242,888 - $346,113	6,033 Added 7.52%	86,298 $3.82 Million
Q2 2021 Aug 02, 2021	BUY	$54.88 - $79.29 $577,118 - $833,813	10,516 Added 15.08%	80,265 $4.56 Million
Q1 2021 May 06, 2021	BUY	$70.65 - $96.76 $2.6 Million - $3.56 Million	36,833 Added 111.9%	69,749 $5.22 Million
Q4 2020 Feb 10, 2021	BUY	$58.41 - $89.06 $927,901 - $1.41 Million	15,886 Added 93.28%	32,916 $2.85 Million
Q3 2020 Nov 12, 2020	BUY	$41.13 - $62.45 $635,047 - $964,228	15,440 Added 971.07%	17,030 $1.04 Million
Q2 2020 Aug 12, 2020	BUY	$25.95 - $43.15 $18,450 - $30,679	711 Added 80.89%	1,590 $66,000
Q1 2020 May 08, 2020	BUY	$26.15 - $77.24 $10,172 - $30,046	389 Added 79.39%	879 $25,000
Q3 2019 Nov 07, 2019	BUY	$140.29 - $189.96 $68,742 - $93,080	490 New	490 $69,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account